We set out to understand how melatonin might help alleviate headaches in children suffering from migraines without sleep disorders. In our study, we worked with fifty-five children aged 5 to 15 years, dividing them into two groups for a three-month treatment period.
One group received propranolol, a standard migraine medication, while the other group combined propranolol with melatonin. We visited the children before treatment, as well as one and three months afterward, to gather and assess their progress.
Our findings revealed that the combination of melatonin with propranolol led to a notable decrease in the frequency of headache attacks among the children receiving the added melatonin. In fact, three months after starting treatment, we observed a significant improvement in response rates and overall satisfaction among parents in the intervention group compared to those only on propranolol.
However, we did not find any significant difference in the intensity of headaches' impact on daily life between the two groups. Thankfully, the treatment was well-tolerated with no major side effects reported.
Overall, our research suggests that adding melatonin could be a beneficial strategy for reducing headache frequency in children with migraines without sleep issues, while also enhancing treatment satisfaction.